Seeking Alpha

Volcano (VOLC) CEO Scott Huennekens has predicted that the market for a test that shows whether...

Volcano (VOLC) CEO Scott Huennekens has predicted that the market for a test that shows whether patients need heart stents could increase ten-fold to $2B within a decade. That would be a boon not only to Volcano, which sells the tests and could become a takeover target, but also to St. Jude Medical (STJ), which is the only other company in the game. Doctors are enthusiastic as data indicates they've been over-stenting.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector